A diagnostic approach to fungal pneumonia: an infectious diseases perspective

MM Azar - Chest, 2023 - Elsevier
Although bacteria significantly exceed fungi as the most common cause of lower respiratory
tract infection, the incidence of fungal pneumonia is increasing because of a growing at-risk …

Pneumocystis jirovecii pneumonia associated with immune checkpoint inhibitors: a systematic literature review of published case reports and disproportionality …

S Xia, H Gong, Y Wang, L Liu, Y Zhao, L Guo… - Frontiers in …, 2023 - frontiersin.org
Background: Pneumocystis jirovecii pneumonia (PJP) has been reported with ICIs but
limited to case reports. The clinical features of PJP with ICIs remain mostly unknown. This …

Pneumocystis infection in two patients treated with both immune checkpoint inhibitor and corticoids

M Sadek, A Loizidou, A Drowart… - Journal of …, 2020 - meridian.allenpress.com
The introduction of immune checkpoint inhibitor (ICI) targeting cytotoxic T-lymphocyte-
associated antigen-4 and programmed cell death receptor 1 has dramatically improved …

Late-onset complications with bendamustine versus CHOP or CVP based chemoimmunotherapy in indolent Non-Hodgkin's lymphoma

GT Baek, NJ Mathis, AJ Perissinotti… - Leukemia & …, 2021 - Taylor & Francis
Bendamustine is a preferred first-line chemoimmunotherapy regimen for indolent non-
Hodgkin's lymphoma (iNHL). Emerging evidence suggests an increased incidence of late …

Imaging Spectrum of Infections in the Setting of Immunotherapy and Molecular Targeted Therapy

M Zulfiqar, C Menias, A Shetty, DR Ludwig… - Current Problems in …, 2022 - Elsevier
Advances in genomics and immunology are revolutionizing our understanding and
treatment of cancer with improved treatment outcomes and patient quality of life. With the …